Mesa Laboratories, Inc. (MLAB)

NASDAQ: MLAB · Real-Time Price · USD
105.26
+3.24 (3.18%)
At close: Jun 1, 2026, 4:00 PM EDT
105.23
-0.03 (-0.03%)
After-hours: Jun 1, 2026, 4:10 PM EDT
Market Cap581.54M -10.9%
Revenue (ttm)249.13M +3.4%
Net Income6.71M
EPS1.21
Shares Out 5.52M
PE Ratio86.99
Forward PE77.40
Dividend$0.64 (0.63%)
Ex-Dividend DateMay 29, 2026
Volume230,862
Open101.62
Previous Close102.02
Day's Range99.47 - 105.72
52-Week Range55.45 - 111.29
Beta0.94
AnalystsBuy
Price Target112.00 (+6.4%)
Earnings DateMay 27, 2026

About MLAB

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the denta... [Read more]

Sector Technology
Founded 1982
Employees 730
Stock Exchange NASDAQ
Ticker Symbol MLAB
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for MLAB stock is "Buy." The 12-month stock price target is $112.0, which is an increase of 6.40% from the latest price.

Price Target
$112.0
(6.40% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical qual...

5 days ago - GlobeNewsWire

Mesa Laboratories Earnings release: Q4 2026

Mesa Laboratories released its Q4 2026 earnings on May 27, 2026, summarizing the period's financial results.

5 days ago - Filings

Mesa Laboratories Slides: Q4 2026

Mesa Laboratories has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 27, 2026.

5 days ago - Filings

Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 202...

27 days ago - GlobeNewsWire

Mesa Labs CEO Gary Owens to step down, Siddhartha Kadia to succeed

Mesa Labs (MLAB) announced that Gary Owens will step down as president and CEO on April 12 and will enable a leadership transition. To lead the company’s next chapter, the…

3 months ago - TheFly

Mesa Labs price target raised to $94 from $83 at Wells Fargo

Wells Fargo raised the firm’s price target on Mesa Labs (MLAB) to $94 from $83 and keeps an Equal Weight rating on the shares. The firm notes the company posted…

4 months ago - TheFly

Mesa Laboratories Quarterly report: Q3 2026

Mesa Laboratories has published its Q3 2026 quarterly earnings report on February 3, 2026.

4 months ago - Filings

Mesa Laboratories Earnings release: Q3 2026

Mesa Laboratories released its Q3 2026 earnings on February 3, 2026, summarizing the period's financial results.

4 months ago - Filings

Mesa Laboratories Transcript: 44th Annual J.P. Morgan Healthcare Conference

The company highlighted its strong recurring revenue base, disciplined growth through both organic initiatives and strategic acquisitions, and resilience amid recent market headwinds. With a focus on regulated markets and continuous operational improvement, it expects accelerating growth as clinical trial activity rebounds.

4 months ago - Transcripts

Mesa Laboratories Slides: 44th Annual J.P. Morgan Healthcare Conference

Mesa Laboratories has posted slides in relation to its latest quarterly earnings report, which was published on January 14, 2026.

4 months ago - Filings

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quart...

5 months ago - GlobeNewsWire

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, to...

5 months ago - GlobeNewsWire

Mesa Labs price target raised to $83 from $75 at Wells Fargo

Wells Fargo raised the firm’s price target on Mesa Labs (MLAB) to $83 from $75 and keeps an Equal Weight rating on the shares. With U.S. policy uncertainty lifting on…

6 months ago - TheFly

Mesa Laboratories Transcript: Jefferies London Healthcare Conference 2025

Biopharmaceutical development and calibration solutions showed strong growth, with regional disparities in clinical genomics due to China headwinds. Cost reductions and reinvestments are supporting commercialization and operational improvements, while M&A and APAC expansion remain strategic priorities.

6 months ago - Transcripts

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences

LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcomin...

7 months ago - GlobeNewsWire

Mesa Labs price target raised to $115 from $110 at Jefferies

Jefferies analyst Tycho Peterson raised the firm’s price target on Mesa Labs (MLAB) to $115 from $110 and keeps a Buy rating on the shares following a Q2 report that…

7 months ago - TheFly

Mesa Laboratories Quarterly report: Q2 2026

Mesa Laboratories has published its Q2 2026 quarterly earnings report on November 6, 2025.

7 months ago - Filings

Mesa Laboratories Earnings release: Q2 2026

Mesa Laboratories released its Q2 2026 earnings on November 6, 2025, summarizing the period's financial results.

7 months ago - Filings

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025

LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market c...

8 months ago - GlobeNewsWire

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financ...

10 months ago - GlobeNewsWire

Mesa Labs upgraded to Equal Weight from Underweight at Wells Fargo

Wells Fargo upgraded Mesa Labs (MLAB) to Equal Weight from Underweight with a price target of $67, down from $100. The firm believes the recent sharp stock selloff appears overdone…

10 months ago - TheFly

Mesa Labs Announces First Quarter Results

LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, to...

10 months ago - GlobeNewsWire

Mesa Laboratories Quarterly report: Q1 2026

Mesa Laboratories has published its Q1 2026 quarterly earnings report on August 5, 2025.

10 months ago - Filings

Mesa Laboratories Earnings release: Q1 2026

Mesa Laboratories released its Q1 2026 earnings on August 5, 2025, summarizing the period's financial results.

10 months ago - Filings

Mesa Laboratories Proxy statement: Proxy Filing

Mesa Laboratories filed a proxy statement on July 11, 2025, providing details for shareholder voting and corporate governance matters.

11 months ago - Filings